SUNSHINE PHARMA (06887) repurchased 16,000 shares for HKD 635,500 on September 28.
Sunshine Pharma (06887) announced that on September 28, 2026, the company repurchased 16,000 shares for HKD 635,500, at a repurchase price of HKD 39.4 to 40 per share.
SUNSHINE PHARMA (06887) announced that on September 28, 2026, the company repurchased 16,000 shares for HKD 635,500, at a repurchase price of HKD 39.4 to HKD 40 per share.
Related Articles
Shanghai Stock Exchange: Shenzhen Kinwong Electronic (03228) and Red Avenue New Materials Group (09607) will be added to the Hong Kong Stock Connect list under the Shanghai-Hong Kong Stock Connect.
Changchun High-Tech Industry (000661.SZ): The domestic production drug registration clinical trial application for Fuxinqibai Monoclonal Antibody Injection has been accepted.
YUK WING GP(01536): Chow Wing Hang Appointed as Company Secretary, Authorized Representative and Process Agent
Shanghai Stock Exchange: Shenzhen Kinwong Electronic (03228) and Red Avenue New Materials Group (09607) will be added to the Hong Kong Stock Connect list under the Shanghai-Hong Kong Stock Connect.
Changchun High-Tech Industry (000661.SZ): The domestic production drug registration clinical trial application for Fuxinqibai Monoclonal Antibody Injection has been accepted.
YUK WING GP(01536): Chow Wing Hang Appointed as Company Secretary, Authorized Representative and Process Agent
